Skip to main content
. 2020 Feb 11;2020(2):CD001122. doi: 10.1002/14651858.CD001122.pub5

Roy 2010.

Methods Prospective randomised trial conducted in India
Timing: January 2006 to January 2009
Participants Women from a gynaecological clinic. Mean age of rosiglitazone group was 27.32 ± 4.25 and for LOD group was 28.42 ± 3.65 years
Inclusion: Age between 20 and 40 years, having primary infertility with clomiphene‐resistant PCOS, documented patent tubes on hysterosalpingography and no other infertility factor, normal semen parameters in partner
Exclusion: Other PCOS‐like syndromes such as Cushings syndrome, congenital adrenal hyperplasia, androgen producing tumours, hyperprolactinaemia and hypothyroidism
Interventions All participants had laparoscopy
Unilateral LOD using 5 punctures + multivitamins twice daily + CC (n = 25), versus
Rosiglitazone 4 mg twice daily + CC (n = 25).
Treatment continued for 6 months after laparoscopy
Outcomes Ovulation, pregnancy, number of follicles, serum E2, endocrine parameters
Notes No conflict of interest
Clinical trial registration number: not stated
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "using online software to generate a random number table"
Allocation concealment (selection bias) Unclear risk Quote: "opening sealed envelopes containing numbers from the computer generated random table"
Comment: Method looks okay but unclear if envelopes were opaque and if they were opened sequentially
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Participants were blinded
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk Outcome assessor was blinded to allocation group
Incomplete outcome data (attrition bias) 
 All outcomes High risk 5 women were lost to follow‐up, an additional 2 women refused to participate before randomisation and therefore 43 were analysed. The reasons for loss to follow‐up are not described
Selective reporting (reporting bias) Unclear risk We could not retrieve the original protocol. The outcomes listed in the Methods section were reported in the Results
Other bias Low risk No evidence of other risk of bias